The neuroprotective effect of fisetin in the MPTP model of Parkinson's disease

Journal of Parkinson's Disease

Volumn 2, Issue 4, 2012, Pages 287-302

  Patel, Mital Y ^a   Panchal, Hirenkumar V ^a   Ghribi, Othman ^b   Benzeroual, Kenza E ^a  

^a LONG ISLAND UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); Apoptosis; Fisetin; MPP+; neurodegeneration; NF B inhibitor; Parkinson's disease; PC12 cells; pro inflammatory cytokines

Indexed keywords

ALPHA SYNUCLEIN; FISETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DNA FRAGMENTATION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; WESTERN BLOTTING;

ALPHA-SYNUCLEIN; ANIMALS; CELL DEATH; CELL SURVIVAL; FLAVONOIDS; MPTP POISONING; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84874850775     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-012110     Document Type: Article

References (74)

1. Lang AE (2007) The progression of Parkinson disease: A hypothesis. Neurology, 68, 948-952. (Pubitemid 46568509)
2. Savitt JM, Dawson VL, & Dawson TM (2006) Diagnosis and treatment of Parkinson disease: Molecules to medicine. J Clin Invest, 116, 1744-1754. (Pubitemid 44033293)
3. Crowther RA, Daniel SE, & Goedert M (2000) Characterization of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain. Neurosci Lett, 92(2), 128-130.
4. Xu J, Kao SY, Lee FJ, Song W, Jin LW, & Yanker BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: A mechanism for selective neurodegeneration in Parkinson disease. Nat Med, 8, 600-606. (Pubitemid 34633438)
5. Zhang Y, Dawson VL, & Dawson TM (2000) Oxidative stress andgenetics in the pathogenesis of Parkinson's disease. Neu-robiol Dis, 7(4), 240-250.
6. Zhou C, Huang Y, & Przedborski (2008) Oxidative Stress in Parkinson's Disease: A mechanism of pathogenic and therapeutic significance. Annals of the New York Academy of Sciences, 1147, 93-104.
7. Marchetti B, & Abbracchio MP (2005) To be or not to be (inflamed) Is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol Sci, 26, 517-525. (Pubitemid 41338562)
8. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, & Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson's disease. The Journal of Neuroscience, 23(34), 10756-10764. (Pubitemid 37499681)
9. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, & Lazebnik YA et al. (1995) Identification and inhibition ofthe ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
10. Slater AF, Nobel CS, Maellaro E, Bustamante J, Kimland M, & Orrenius S (1995) Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apopto-sis. Biochem J, 306, 771-778.
11. O'Brien NM, Woods JA, Aherne SA, & O'Callaghan YC (2000) Cytotoxicity, genotoxicity and oxidative reactions in cell-culture models: Modulatory effects of phytochemicals. Biochem Soc Trans, 28, 22-26. (Pubitemid 30103207)
12. Kakimura J, Kitamura Y, Takata K, Kohno Y, Nomura Y, & Taniguchi T (2001) Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole. Eur J Pharmacol, 417(1-2), 59-67. (Pubitemid 32299869)
13. Broughton BR, Reutens DC, & Sobey CG (2009) Apop-totic mechanisms after cerebral ischemia. Stroke, 40, e331-e339.
14. Hashimoto M, Takeda A, Hsu LJ, Takenouchi T, & Masliah E (1999) Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease. J Biol Chem, 274(41), 28849-28852.
15. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, & Agid Y (1997) Apoptosis and autophagy in nigral neurons of patientswith Parkinson's disease. Histol Histopathol, 12, 25-31. (Pubitemid 27106916)
16. Mochizuki H, Goto K, Mori H, & Mizuno Y (1996) His-tochemical detection of apoptosis in Parkinson's disease. J Neurol Sci, 137, 120-123. (Pubitemid 26172041)
17. Mochizuki H, Nakamura N, Nishi K, & Mizuno Y (1994) Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat. Neurosci Lett, 170, 191-194. (Pubitemid 24117319)
18. Speciale SG (2002) MPTP: Insights into parkinsonian neu-rodegeneration. Neurotoxicol Teratol, 24, 607-620.
19. Tatton NA, & Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience, 77, 1037-1048.
20. Singer TP, & Ramsay RR (1990) Mechanism of the neuro-toxicity of MPTP, an update. FEBS Lett, 274, 1-8.
21. Alcaraz-Zubeldia M, Rojas P, Boll C, & Rios C (2001) Neuro-protective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice. Neurochem Res, 26, 59-64. (Pubitemid 32428814)
22. Saporito MS, Thomas BA, Scott RW (2000) MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J Neurochem, 75, 1200-1208. (Pubitemid 30660510)
23. +-induced cell deathinPC12 cells. Korean J Physiol Pharmacol, 12(2), 65-71. (Pubitemid 351736661)
24. Lee HJ, Shin SY, Choi C, Lee YH, & Lee SJ (2002) Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J Biol Chem, 277, 5411-5417. (Pubitemid 34968588)
25. Kalivendi SV, Cunningham S, Kotamraju S, Joseph J, Hillard CJ, & Kalyanaraman B (2004) Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neurob-lastoma cells: Intermediacy of transferrin receptor iron and hydrogen peroxide. J Biol Chem, 279, 15240-15247. (Pubitemid 38618920)
26. Aquilano K, Baldelli S, Rotilio G, & Ciriolo MR (2008) Role of nitric oxide synthases in Parkinson's disease: A review on the antioxidantand anti-inflammatory activityofpolyphenols. Neurochem Res, 33, 2416-2426.
27. Kavya R, Saluja R, Singh, & Dikshit SM (2006) Nitric oxide synthase regulation and diversity: Implications in Parkinson's disease. Nitric Oxide, 15, 280-294. (Pubitemid 44647899)
28. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, & Przed-borski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med, 5, 1403-1409.
29. Xu Z, Cawthon D, McCastlain KA, Duhart HM, Newport GD, Fang H, Patterson TA, Slikker W Jr, & Ali SF (2005) Selective alterationsoftranscription factorsinMPP+-induced neurotoxicity in PC12 cells. Neurotoxicology, 26, 729-737. (Pubitemid 41175905)
30. Dauer W, & Przedborski S (2003) Parkinson's disease: Mechanisms and models. Neuron, 39, 889-909. (Pubitemid 37130207)
31. Halliwell B (2006) Oxidative stress and neurodegeneration: Where are we now? J Neurochem, 97(6), 1634-1658. (Pubitemid 43873658)
32. Glass CK, Saijo K, Winner B, Marchetto MC, & Gage FH (2010) Mechanisms Underlying Inflammation in Neurodegeneration. Cell, 140(6), 918-934.
33. Middleton E Jr, Kandaswami C, & Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev, 52, 673-751.
34. Rice-Evans C (2001) Flavonoid antioxidants. Curr Med Chem, 8(7), 797-807. (Pubitemid 32427907)
35. Bastianetto S, Zheng WH, & Quirion R (2000) Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol, 131(4), 711-720.
36. Sengupta B, Banerjee A, & Sengupta PK (2004) Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes. FEBS Letters, 570, 77-81. (Pubitemid 38900960)
37. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, & Kinae N (2000) Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr, 130(9), 2243-2250.
38. Maher P (2009) Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes Nutr, 4(4), 297-307.
39. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, & Dexter DT (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res, 39(10), 1119-1125. (Pubitemid 41358566)
40. Manach C, & Donovan J (2004) Pharmacokinetics and Metabolism of dietary fiavonoids. Free Rad Res, 38, 771-785.
41. Ishige K, Schubert D, & Sagara Y (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med, 30(4), 433-446. (Pubitemid 32155542)
42. Sagara Y, Vanhnasy J, & Maher P. (2004) Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J Neurochem, 90(5), 1144-1155. (Pubitemid 39167347)
43. Maher P (2006) A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives. Free Radic Res, 40(10), 1105-1111. (Pubitemid 44480551)
44. Maher P (2008) The flavonoid fisetin promotes nerve cell survival from trophic withdrawal by enhancement of proteasome activity. Arch Biochem Biophys, 476, 139-144.
45. Girish V, & Vijayalakshmi A (2004) Affordable image analysis using NIH Image/ImageJ. Indian J Cancer, 41, 47. (Pubitemid 38623932)
46. Cookson MR (2009) a-Synuclein and neuronal cell death. Molecular Neurodegeneration, 4, 9.
47. Cappai R, Leck SL, Tew DJ, Williamson NA, Smith DP, Galattis D, Sharples RA, Curtain CC, Ali FE, Cherry RA, Cul-vernor JG, Bottomley SP, Masters CL, Barnham KJ, & Hill AF (2005) Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J, 9, 1377-1379. (Pubitemid 41113755)
48. Prasad JE, Kumar B, Andreatta C, Nahreini P, Hanson AJ, Yan XD, & Prasad KN (2004) Overexpression of alpha-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells. J Neurosci Res, 76, 415-422. (Pubitemid 38580137)
49. O'Neill Luke AJ, & Kaltschmidt C (1997) NF-kB: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci, 20, 252-258. (Pubitemid 27261456)
50. Mattson MP, & Meffert MK (2006) Roles for NF-kB in nerve cell survival, plasticity, and disease. Cell Death Differ, 13, 852-860.
51. Singh S, & Dikshit M (2007) Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide. Brain Research Reviews, 54(2), 233-250. (Pubitemid 46891075)
52. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, & Oltvai ZN (1993) Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol, 4, 327-332. (Pubitemid 2028596)
53. Hartley A, Stone JM, Heron C, Cooper JM, & Schapira AH (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease. JNeurochem, 63, 1987-1990. (Pubitemid 24326248)
54. Ansari N, Khodagholi F, Amini M, & Shaerzadeh F (2011) Attenuation of LPS-induced apoptosis in NGF-differentiated PC12 cells via NF-kB pathway and regulation of cellular redox status by an oxazine derivative. Biochimie, 93(5), 899-908.
55. Dholakiya SL, & Benzeroual KE (2011) Protective effect of diosmin on LPS-induced apoptosis in PC12 cells and inhibition of TNF-a expression. Toxicology In Vitro, 25(5), 1039-1044.
56. Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, Yang L, Flint Beal M, & Andersen JK (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease. The Journal of Neuroscience, 21(24), 9519-9528. (Pubitemid 34184040)
57. Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, & Spencer JPE (2008) The neuroprotective potential of flavonoids: A multiplicity of effects. GenesNutr, 3(3-4), 115-126.
58. Xua J, Weib C, Xuc C, Bennettc CM, Zhanga G, Lia F, & Taoa E (2007) Rifampicin protects PC12 cells against MPP+ induced apoptosis and inhibits expression of alpha-Synuclein oligomers. Brain Research, 1139, 220-225.
59. Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, & Przedborski S (2000) a-Synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP J Neurochem, 74, 721-729. (Pubitemid 30053745)
60. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mal-lory M, Wong J, Takenouchi T, Hashimoto M, & Masliah E (2000) Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol, 157, 401-410. (Pubitemid 30627559)
61. Watanabe Y, Himeda T, & Araki T (2005) Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease. Med Sci Monit, 11, RA17-RA23. (Pubitemid 40116407)
62. Saha AR, Ninkina NN, Hanger DP, Anderton BH, Davies AM, & Buchman VL (2000) Induction of neuronal death by alpha-synuclein. Eur J Neurosci, 12, 3073-3077.
63. Smith WW, Jiang H, Pei Z, Tanaka Y, Morita H, Sawa A, Dawson VL, Dawson TM, & Ross CA (2005) Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet, 14, 3801-3811. (Pubitemid 43020082)
64. Kruman I, Guo Q, & Mattson MP (1998) Calcium andreactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res, 51, 293-308. (Pubitemid 28078461)
65. Ba F, Pang PKT, & Benishin CG (2003) The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. Journal of Neuroscience Methods, 123(1), 11-22. (Pubitemid 36173648)
66. Qureshi HY, & Paudel HK (2011) Parkinsonian neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and a-synuclein mutations promote tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in Vitro. J Biol Chem, 286(7), 5055-5068.
67. Gross A, McDonnell JM, & Korsmeyer SJ (1999) Bcl-2 family members and the mitochondria in apoptosis. Genes Dev, 13, 1899-1911. (Pubitemid 29407357)
68. Auluck PK, Caraveo G, & Lindquist S (2010) a-Synuclein: Membrane interactions and toxicity in Parkinson's disease. Annual Review of Cell and Developmental Biology, 26, 211-233.
69. Gao HM, Liu B, Zhang W, & Hong JS (200) (2003) Novel anti-inflammatory therapy for Parkinson's disease. Trends in Pharmacological Sciences, 24(8), 395-401. (Pubitemid 36952555)
70. McGeer PL, & McGeer EG (2004) Inflammation and neu-rodegeneration in Parkinson's disease. Parkinsonism Relat Disord, 10(1), S3-S7.
71. Tansey MG, McCoy MK, & Frank-Cannon TC (2007) Neu-roinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol, 208(1), 1-25. (Pubitemid 47603240)
72. Feng ZH, Wang TG, Li DD, Fung P, Wilson BC, Liu B, Ali SF, Langenbach R, & Hong JS (2002) Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett, 329, 354-358. (Pubitemid 35245358)
73. Chera B, Schaecher KE, Rocchini A, Imam SZ, Sribnick EA, Ray SK, Ali SF, & Banik NL (2004) Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice. Brain Res, 1006, 150-156. (Pubitemid 38393759)
74. Wang C, Sadovova N, Ali HK, Duhart HM, Fu X, Zou X, Patterson TA, Binienda ZK, Virmani A, Paule MG, Slikker W Jr, & Ali SF (2007) L-Carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture. Neuroscience, 144, 46-55. (Pubitemid 44848384)